Cleared Traditional

K242924 - OPXION Optical Skin Viewer (OPXSV1-01F) (FDA 510(k) Clearance)

Jun 2025
Decision
272d
Days
Class 2
Risk

K242924 is an FDA 510(k) clearance for the OPXION Optical Skin Viewer (OPXSV1-01F). This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).

Submitted by Opxion Technology, Inc. (New Taipei City, TW). The FDA issued a Cleared decision on June 23, 2025, 272 days after receiving the submission on September 24, 2024.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..

Submission Details

510(k) Number K242924 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2024
Decision Date June 23, 2025
Days to Decision 272 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NQQ - System, Imaging, Optical Coherence Tomography (oct)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.